Print ISSN: 2395-1443
Online ISSN: 2395-1451
CODEN : IJCEKF
Indian Journal of Clinical and Experimental Ophthalmology (IJCEO) is open access, a peer-reviewed medical journal, published quarterly, online, and in print, by the Innovative Education and Scientific Research Foundation (IESRF) since 2015. To fulfil our aim of rapid dissemination of knowledge, we publish articles ‘Ahead of Print’ on acceptance. In addition, the journal allows free access (Open Access) to its content, which is likely to attract more readers and citations of articles published in IJCEO. Manuscripts must be prepared in more...Case Report
Author Details :
Volume : 8, Issue : 2, Year : 2022
Article Page : 308-310
https://doi.org/10.18231/j.ijceo.2022.062
Abstract
Many ocular manifestations such as conjunctival congestion and central retinal artery occlusion were noticed in covid and post-covid patients, ut a case of bilateral symmetrical intermediate uveitis in post covid patient has been very rarely reported till date. A 62-year old hypertensive female who suffered from COVID 19 illness complained of diminution of vision for both distance and near along with complaints of floaters in both the eyes three months after covid recovery. After carrying out detailed systemic and ophthalmic evaluation, she was diagnosed with bilateral symmetrical intermediate uveitis which responded very well to tapering doses of oral and topical steroids. Early diagnosis and intervention is very essential to treat a y ocular symptoms in post-covid patients to regain normal visual acuity.
This is a very rare case of bilateral symmetrical intermediate uveitis in post-covid Indian patient which is responsive systemic and topical steroids.
Keywords: Intermediate uveitis, Post covid, Macular oedema, Steroids.
How to cite : Swati Barne S, Joshi Devika S, Beke Nikhil N, A case report of bilateral, symmetrical intermediate uveitis in a post COVID 19 Indian patient. Indian J Clin Exp Ophthalmol 2022;8(2):308-310
This is an Open Access (OA) journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.